Clinical Trials Logo

Clinical Trial Summary

Non-interventional study to evaluate safety and efficacy of NOVOCART® Inject in patients with full thickness cartilage defects in the hip.


Clinical Trial Description

Prospective and multicenter non-interventional study to evaluate safety and efficacy of NOVOCART® Inject in patients with impingement syndrom in the hip.

Safety: 24-month post treatment follow up period by measuring the number of adverse drug reactions/serious adverse drug reactions.

Efficacy: 24-month post treatment follow up period using iHOT 33 and EuroQuol-5D-5L. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02179346
Study type Observational
Source Tetec AG
Contact
Status Completed
Phase
Start date December 2014
Completion date June 18, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT02991300 - BioPoly® RS Partial Resurfacing Patella Registry Study
Withdrawn NCT00961597 - Assessment of Outcome of Meniscus Repair With or Without Platelet Rich Plasma N/A
Not yet recruiting NCT05391841 - Non-interventional Study in Pediatric Patients Treated With NOVOCART Inject in the Knee
Recruiting NCT04785092 - All Autologous Cartilage Regeneration in the Treatment of the Knee Cartilage Defects N/A
Completed NCT02941120 - Non-interventional Study With NOVOCART® Inject in the Reconstruction of the Knee Cartilage Defects
Recruiting NCT04537013 - Clinical Study of Chondro-Gide® for Large Chondral Lesions in the Knee N/A
Not yet recruiting NCT06238947 - Long-term Outcome Evaluation of Patients Undergoing Autologous Chondrocyte Transplantation Delivered on Biomaterial
Active, not recruiting NCT04186208 - Non-interventional Study With NOVOCART® 3D for the Treatment of Cartilage Defects of the Knee in Pediatric Patients